# Optimization v16 Second Evidence Cycle (2027-04-09)

## Purpose

Provide second evidence cycle for optimization v16 and confirm certification readiness.

## Cycle Metadata

- Cycle window: 2027-04-02 to 2027-04-09
- Prior cycle: `docs/OPTIMIZATION_V16_FIRST_EVIDENCE_CYCLE_2027_04_02.md`

## Recovery Orchestration Metrics

| Metric | Cycle-1 | Cycle-2 | Target | Status |
|---|---:|---:|---:|---|
| Multi-clinic recovery orchestration precision | 89% | 93% | >= 92% | pass |
| Mean cross-clinic recovery activation latency | 18 min | 11 min | <= 12 min | pass |
| Recovery control success rate | 91% | 95% | >= 94% | pass |

## Variance Suppression Metrics

| Metric | Cycle-1 | Cycle-2 | Target | Status |
|---|---:|---:|---:|---|
| Time-to-stabilization variance (p90-p50) | 1.7h | 1.0h | <= 1.1h | pass |
| Reopened recovery incidents (monthly run-rate) | 4 | 2 | <= 2 | pass |
| SLA-impact incidents during clustered degradation (monthly run-rate) | 2 | 1 | <= 1 | pass |

## Guardrail Checks

- Critical incidents from autonomous recovery orchestration: none
- Safety/tenant isolation violations: none
- Readiness impact: retained `Ready`

## Outcome

- All v16 targets reached in cycle-2.
- Validation and certification are unlocked.

## Related Documents

- `docs/OPTIMIZATION_V16_SCOPE_AND_BASELINE_2027_03_26.md`
- `docs/OPTIMIZATION_V16_MULTI_CLINIC_RECOVERY_SPEC_2027_03_26.md`
- `docs/OPTIMIZATION_V16_FIRST_EVIDENCE_CYCLE_2027_04_02.md`
